The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Gulf War and Health: Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, Vaccines
nervous system disease,
nonmalignant respiratory disease, or
other health outcomes (gastrointestinal disease, immune-mediated disease, effects on hematological parameters, reproductive or development dysfunction, genotoxic effects, cardiovascular effects, hepatic disease, dermal effects, ocular effects, or musculoskeletal effects).
Archer VE, Wagoner JK, Lundin FE Jr. 1973a. Cancer mortality among uranium mill workers. J Occup Med 15(1):11–14.
Archer VE, Wagoner JK, Lundin FE. 1973b. Lung cancer among uranium miners in the United States. Health Phys 25(4):351–371.
Archer VE, Gilman JD, Wagoner JK. 1976. Respiratory disease mortality among uranium miners. Ann NY Acad Sci 271:280–293.
Archer VE, Renzetti AD, Doggett RS, Jarvis JQ, Colby TV. 1998. Chronic diffuse interstitial fibrosis of the lung in uranium miners. J Occup Environ Med 40(5):460–474.
ATSDR (Agency for Toxic Substances and Disease Registry). 1999a. Toxicological Profile for Ionizing Radiation. Atlanta, GA: ATSDR
ATSDR (Agency for Toxic Substances and Disease Registry). 1999b. Toxicological Profile for Uranium. Atlanta, GA: ATSDR.
Auerbach O, Saccomanno G, Kuschner M, Brown RD, Garfinkel L. 1978. Histologic findings in the tracheobronchial tree of uranium miners and non-miners with lung cancer. Cancer 42(2):483–489.
Band P, Feldstein M, Saccomanno G, Watson L, King G. 1980. Potentiation of cigarette smoking and radiation: Evidence from a sputum cytology survey among uranium miners and controls. Cancer 45(6):1273–1277.
Bassett SH, Frenkel A, Cedars N, et al. 1948. The excretion of hexavalent uranium following intravenous administration. II. Studies on human subjects. USAEC Report UR-37. As cited in: ATSDR (Agency for Toxic Substances and Disease Registry). 1999. Toxicological Profile for Uranium. Atlanta, GA: ATSDR.
Baur X, Rihs HP, Altmeyer P, Degens P, Conrad K, Mehlhorn J, Weber K, Wiebe V. 1996. Systemic sclerosis in German uranium miners under special consideration of autoantibody subsets and HLA class II alleles. Respiration 63:368–375.
Berlin M, Rudell B. 1986. Uranium. In: Friberg L, Nordberg G, Vouk V, eds. Handbook on the Toxicology of Metals, 2nd edition. Amsterdam: Elsevier Science. Pp. 623–637.
Bernard SR. 1958. Maximum permissible amounts of natural uranium in the body, air and drinking water based on human experimental data. Health Phys 1:288–305.
Boback MW. 1975. A review of uranium excretion and clinical urinalysis data in accidental exposure cases. In: Wrenn ME, ed. Conference on Occupational Health Experience with Uranium. Washington, DC: U.S. Energy Research and Development Administration. ERDA-93. Pp. 225–243.
Brady HR, Kone BC, Brenner RM, Gullans SR. 1989. Early effects of uranyl nitrate on respiration and K+ transport in rabbit proximal tubule. Kidney Int 36(1):27–34.
Breslow NE, Day NE. 1987. Statistical Methods in Cancer Research.Vol.2.The Design and Analysis of Cohort Studies. Lyon: International Agency for Research on Cancer. IARC Scientific Pub. No. 82.